SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 953.60 |
| Enterprise Value ($M) | 1,050.20 |
| Book Value ($M) | 1,365.40 |
| Book Value / Share | 2.03 |
| Price / Book | 0.70 |
| NCAV ($M) | -172.70 |
| NCAV / Share | -0.26 |
| Price / NCAV | -5.52 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.03 |
| Return on Assets (ROA) | -0.03 |
| Return on Equity (ROE) | -0.04 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.10 |
| Current Ratio | 3.43 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 662.10 |
| Assets | 2,200.20 |
| Liabilities | 834.80 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 713.10 |
| Operating Income | -273.60 |
| Net Income | -53.20 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -183.49 |
| Cash from Investing | 352.21 |
| Cash from Financing | 184.17 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Frost Phillip Md Et Al | 31.70 | 0.77 | |
| 13D/A | Hsiao Jane Ph D | 4.50 | -0.28 | |
| 13G | Rubric Capital Management LP | 6.98 | ||
| 13G/A | Vanguard Group Inc | 4.18 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K/A Amendment No. 1 | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 318,890 | 1,632,209 | 19.54 | |
| 417,084 | 1,808,360 | 23.06 | |
| 540,704 | 2,227,607 | 24.27 | |
| 389,313 | 2,079,415 | 18.72 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NXTC – NextCure, Inc. | OGI – Organigram Global Inc. |
| OLMA – Olema Pharmaceuticals, Inc. | OPTN – OptiNose, Inc. |
| ORIC – ORIC Pharmaceuticals, Inc. |